Adenosine derivatives as A2A receptor agonists
US8188100B2 · kind B2 · utility
0Cited by
14References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2007 |
| Grant date | May 29, 2012 |
| Priority date | — |
| Expiry date | Jun 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I), or stereoisomers or pharmaceutically acceptable salts thereof, formula (1), or stereoisomers or pharmaceutically acceptable salts thereof, wherein A, U1, U2, R1a, R1b, R2 and R3 have the meanings as indicated in the specification, are useful for treating conditions mediated by activation of the adenosine A2A receptor, especially inflammatory or obstructive airways diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.